Gut microbiota composition and functional changes in inflammatory bowel disease and irritable bowel syndrome
Arnau Vich Vila,Floris Imhann,Valerie Collij,Soesma A Jankipersadsing,Thomas Gurry,Zlatan Mujagic,Alexander Kurilshikov,Marc Jan Bonder,Xiaofang Jiang,Ettje F Tigchelaar,Jackie Dekens,Vera Peters,Michiel D Voskuil,Marijn C Visschedijk,Hendrik M van Dullemen,Daniel Keszthelyi,Morris A Swertz,Lude Franke,Rudi Alberts,Eleonora A M Festen,Gerard Dijkstra,Ad A M Masclee,Marten H Hofker,Ramnik J Xavier,Eric J Alm,Jingyuan Fu,Cisca Wijmenga,Daisy M A E Jonkers,Alexandra Zhernakova,Rinse K Weersma,Soesma A. Jankipersadsing,Ettje F. Tigchelaar,Michiel D. Voskuil,Marijn C. Visschedijk,Hendrik M. van Dullemen,Morris A. Swertz,Eleonora A. M. Festen,Ad A. M. Masclee,Marten H. Hofker,Ramnik J. Xavier,Eric J. Alm,Daisy M. A. E. Jonkers,Rinse K. Weersma
DOI: https://doi.org/10.1126/scitranslmed.aap8914
IF: 17.1
2018-12-19
Science Translational Medicine
Abstract:Differences in gut microbiota composition and function were observed between patients with inflammatory bowel disease or irritable bowel syndrome.
cell biology,medicine, research & experimental